Oracle shares surge 3.34% as rebuttal to OpenAI delay report and healthcare contracts boost confidence

Generado por agente de IAAinvest Pre-Market RadarRevisado porAInvest News Editorial Team
martes, 23 de diciembre de 2025, 8:02 am ET1 min de lectura

Oracle shares surged 3.34% in pre-market trading on December 23, 2025, driven by renewed investor confidence in its AI infrastructure positioning.

The upward momentum followed Oracle's rebuttal of a Bloomberg report suggesting OpenAI's data-center work would delay to 2028, easing fears over execution risks for a key revenue catalyst. Concurrently, new healthcare contracts—including Mt. San Rafael Hospital adopting

Health—provided tangible near-term visibility, reinforcing growth in cloud software services.

Analysts highlighted that recent market volatility had overstated Oracle's fundamentals, prompting a "buy the dip" narrative. However, Goldman Sachs' sharp price target cut to $220 from $320 underscored lingering concerns about AI capital expenditures and debt management. Broader industry-wide selloffs in AI infrastructure stocks also weighed on sentiment, though Oracle's customer wins and strategic clarity helped offset some of the pressure.

Investors remain focused on upcoming disclosures regarding OpenAI timelines, capex guidance, and potential analyst revisions to gauge the next phase of Oracle's trajectory in the competitive cloud-AI landscape.

author avatar
Ainvest Pre-Market Radar

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios